Lysophosphatidylcholine-induced apoptosis in H19-7 hippocampal progenitor cells is enhanced by the upregulation of Fas Ligand

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1791, Issue 1, 2009, Pages 61-68

  Sun, Yuanjie ^a   Lee, Joo Hyun ^a   Kim, Nam Ho ^a   Lee, Chang Wook ^a   Kim, Min Ju ^a   Kim, Seung Hyuk ^a   Huh, Sung Oh ^a  

^a Institute of Natural Medicine   (South Korea)

Author keywords

Apoptosis; Fas; FasL; H19 7 cell; Lysophosphatidylcholine; NF B

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; FAS ANTIGEN; FAS LIGAND; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPID; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CULTURE; CELL STRAIN H19 7; CELL TYPE; DNA FRAGMENTATION; GENETIC TRANSFECTION; HIPPOCAMPUS; LEUKOCYTE MIGRATION; NERVE CELL; NEURAL STEM CELL; NEUROLOGIC DISEASE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CASPASES; CELL CYCLE PROTEINS; CELLS, CULTURED; FAS LIGAND PROTEIN; HIPPOCAMPUS; LYSOPHOSPHATIDYLCHOLINES; NF-KAPPA B; RATS; RECEPTORS, G-PROTEIN-COUPLED; STEM CELLS; UP-REGULATION;

EID: 57649143644     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2008.09.007     Document Type: Article

References (54)

1. Graler M.H., and Goetzl E.J. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim. Biophy. Acta 1582 (2002) 168-174
2. Ishii I., Fukushima N., Ye X., and Chun J. Lysophospholipid receptors: signaling and biology. Ann. Rev. Biochem. 73 (2004) 321-354
3. Moolenaar W.H. Bioactive lysophospholipids and their G protein-coupled receptors. Exp. Cell Res. 253 (1999) 230-238
4. Gimbrone Jr. M.A. Vascular endothelium: an integrator of pathophysiologic stimuli in atherosclerosis. Am. J. Cardiol. 75 (1995) 67B-70B
5. Steinberg S.F., Kaplan L.M., Inouye T., Zhang J.F., and Robinson R.B. Alpha-1 adrenergic stimulation of 1,4,5-inositol trisphosphate formation in ventricular myocytes. J. Pharmacol. Exp. Ther. 250 (1989) 1141-1148
6. Witztum J.L., and Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88 (1991) 1785-1792
7. Vadas P., and Pruzanski W. Role of secretory phospholipases A2 in the pathobiology of disease. Lab. Invest. J. Tech. Methods Pathol. 55 (1986) 391-404
8. Miwa Y., Hirata K., Kawashima S., Akita H., and Yokoyama M. Lysophosphatidylcholine inhibits receptor-mediated Ca2+ mobilization in intact endothelial cells of rabbit aorta. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 1561{single bond}1567
9. Kugiyama K., Kerns S.A., Morrisett J.D., Roberts R., and Henry P.D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344 (1990) 160-162
10. Murugesan M., Ramachandra Rao M.S., Gupta L.C., Pinto R., Sharon M., and Vijayaraghavan R. Strong rare-earth size dependence of Tc in RSr2Cu2.85Re0.15Oz. Phys. Rev. 53 (1996) 8604-8607
11. Zhu K., Baudhuin L.M., Hong G., Williams F.S., Cristina K.L., Kabarowski J.H., Witte O.N., and Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J. Biol. Chem. 276 (2001) 41325-41335
12. Hla T. Sphingosine 1-phosphate receptors. Prostaglandins 64 (2001) 135-142
13. Trejo J., Altschuler Y., Fu H.W., Mostov K.E., and Coughlin S.R. Protease-activated receptor-1 down-regulation: a mutant HeLa cell line suggests novel requirements for PAR1 phosphorylation and recruitment to clathrin-coated pits. J. Biol. Chem. 275 (2000) 31255-31265
14. Lin P., and Ye R.D. The lysophospholipid receptor G2A activates a specific combination of G proteins and promotes apoptosis. J. Biol. Chem. 278 (2003) 14379-14386
15. Murakami N., Yokomizo T., Okuno T., and Shimizu T. G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine. J. Biol. Chem. 279 (2004) 42484-42491
16. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
17. Radu C.G., Yang L.V., Riedinger M., Au M., and Witte O.N. T cell chemotaxis to lysophosphatidylcholine through the G2A receptor. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 245-250
18. Yang L.V., Radu C.G., Wang L., Riedinger M., and Witte O.N. Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A. Blood 105 (2005) 1127-1134
19. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26 (1972) 239-257
20. Ceccatelli S., Tamm C., Sleeper E., and Orrenius S. Neural stem cells and cell death. Toxicol. Lett. 149 (2004) 59-66
21. Nagata S. Apoptosis by death factor. Cell 88 (1997) 355-365
22. Takahashi T., Tanaka M., Brannan C.I., Jenkins N.A., Copeland N.G., Suda T., and Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76 (1994) 969-976
23. Dhein J., Walczak H., Baumler C., Debatin K.M., and Krammer P.H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373 (1995) 438-441
24. Rothstein T.L., Wang J.K., Panka D.J., Foote L.C., Wang Z., Stanger B., Cui H., Ju S.T., and Marshak-Rothstein A. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374 (1995) 163-165
25. Raoul C., Henderson C.E., and Pettmann B. Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J. Cell Biol. 147 (1999) 1049-1062
26. Park C., Sakamaki K., Tachibana O., Yamashima T., Yamashita J., and Yonehara S. Expression of fas antigen in the normal mouse brain. Biochem. Biophys. Res. Commun. 252 (1998) 623-628
27. Cheema Z.F., Wade S.B., Sata M., Walsh K., Sohrabji F., and Miranda R.C. Fas/Apo [apoptosis]-1 and associated proteins in the differentiating cerebral cortex: induction of caspase-dependent cell death and activation of NF-kappaB. J. Neurosci. 19 (1999) 1754-1770
28. Lu B., Wang L., Medan D., Toledo D., Huang C., Chen F., Shi X., and Rojanasakul Y. Regulation of Fas (CD95)-induced apoptosis by nuclear factor-kappaB and tumor necrosis factor-alpha in macrophages. Am. J. Physiol. 283 (2002) C831-838
29. Kasibhatla S., Genestier L., and Green D.R. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. J. Biol. Chem. 274 (1999) 987-992
30. Ouaaz F., Li M., and Beg A.A. A critical role for the RelA subunit of nuclear factor kappaB in regulation of multiple immune-response genes and in Fas-induced cell death. J. Exp. Med. 189 (1999) 999-1004
31. Dudley E., Hornung F., Zheng L., Scherer D., Ballard D., and Lenardo M. NF-kappaB regulates Fas/APO-1/CD95- and TCR- mediated apoptosis of T lymphocytes. Eur. J. Immunol. 29 (1999) 878-886
32. Glinghammar B., Inoue H., and Rafter J.J. Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-kB and AP-1. Carcinogenesis 23 (2002) 839-845
33. Lambert C., Landau A.M., and Desbarats J. Fas-beyond death: a regenerative role for Fas in the nervous system. Apoptosis 8 (2003) 551-562
34. Eves E.M., Boise L.H., Thompson C.B., Wagner A.J., Hay N., and Rosner M.R. Apoptosis induced by differentiation or serum deprivation in an immortalized central nervous system neuronal cell line. J. Neurochem. 67 (1996) 1908-1920
35. Eves E.M., Skoczylas C., Yoshida K., Alnemri E.S., and Rosner M.R. FGF induces a switch in death receptor pathways in neuronal cells. J. Neurosci. 21 (2001) 4996-5006
36. Wang L., Radu C.G., Yang L.V., Bentolila L.A., Riedinger M., and Witte O.N. Lysophosphatidylcholine-induced surface redistribution regulates signaling of the murine G protein-coupled receptor G2A. Mol. Biol. Cell 16 (2005) 2234-2247
37. Sipe K.J., Srisawasdi D., Dantzer R., Kelley K.W., and Weyhenmeyer J.A. An endogenous 55 kDa TNF receptor mediates cell death in a neural cell line. Brain Res. 38 (1996) 222-232
38. Matsui K., Fine A., Zhu B., Marshak-Rothstein A., and Ju S.T. Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J Immunol. 161 (1998) 3469-3473
39. Singh N.P., Nagarkatti M., and Nagarkatti P.S. Role of dioxin response element and nuclear factor-kappaB motifs in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated regulation of Fas and Fas ligand expression. Mol. Pharmacol. 71 (2007) 145-157
40. George J., Harats D., Gilburd B., Levy Y., Langevitz P., and Shoenfeld Y. Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis. Lupus 8 (1999) 220-226
41. Croset M., Brossard N., Polette A., and Lagarde M. Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem. J. 345 Pt 1 (2000) 61-67
42. Chen G., Li J., Qiang X., Czura C.J., Ochani M., Ochani K., Ulloa L., Yang H., Tracey K.J., Wang P., Sama A.E., and Wang H. Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis. J. Lipid Res. 46 (2005) 623-627
43. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science (New York, N.Y) 281 (1998) 1305-1308
44. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science (New York, N.Y) 281 (1998) 1309-1312
45. Thornberry N.A., and Lazebnik Y. Caspases: enemies within. Science (New York, N.Y) 281 (1998) 1312-1316
46. Pan M.H., Chiou Y.S., Cheng A.C., Bai N., Lo C.Y., Tan D., and Ho C.T. Involvement of MAPK, Bcl-2 family, cytochrome c, and caspases in induction of apoptosis by 1,6-O,O-diacetylbritannilactone in human leukemia cells. Mol. Nutr. Food Res. 51 (2007) 229-238
47. Matsumoto N., Imamura R., and Suda T. Caspase-8- and JNK-dependent AP-1 activation is required for Fas ligand-induced IL-8 production. FEBS J. 274 (2007) 2376-2384
48. Zanker K.S., Eckl P., and Mihich E. International symposium on tumour escape and its determinants: meeting report. Cancer Immunol. Immunother. 55 (2006) 229-233
49. Wilson M., Reddi K., and Henderson B. Cytokine-inducing components of periodontopathogenic bacteria. J. Periodontal Res. 31 (1996) 393-407
50. Kuan C.Y., Yang D.D., Samanta Roy D.R., Davis R.J., Rakic P., and Flavell R.A. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22 (1999) 667-676
51. Raoul C., Pettmann B., and Henderson C.E. Active killing of neurons during development and following stress: a role for p75(NTR) and Fas?. Curr. Opin. Neurobiol. 10 (2000) 111-117
52. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., and Baldwin Jr. A.S. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19 (1999) 5785-5799
53. Westerheide S.D., Mayo M.W., Anest V., Hanson J.L., and Baldwin Jr. A.S. The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition. Mol. Cell. Biol. 21 (2001) 8428-8436
54. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 (1999) 6853-6866